TuisPEN • NYSE
add
Penumbra Inc
Vorige sluiting
$257,88
Dagwisseling
$247,94 - $255,63
Jaarwisseling
$148,00 - $277,34
Markkapitalisasie
9,62 mjd USD
Gemiddelde volume
350,18 k
P/V-verhouding
291,34
Dividend-opbrengs
-
Primêre beurs
NYSE
Marknuus
Investing.com
20 minute gelede
Morning Bid: S&P500 wipes post-election gains as bonds haunt By Reuters
1,54%
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 301,04 m | 11,11% |
Bedryfskoste | 164,94 m | 12,30% |
Netto inkomste | 29,53 m | 220,46% |
Netto winsgrens | 9,81 | 188,53% |
Wins per aandeel | 0,85 | 26,87% |
EBITDA | 39,51 m | 4,60% |
Effektiewe belastingkoers | 25,77% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 291,02 m | 16,95% |
Totale bates | 1,48 mjd | 0,73% |
Totale aanspreeklikheid | 374,84 m | 2,91% |
Totale ekwiteit | 1,10 mjd | — |
Uitstaande aandele | 38,38 m | — |
Prys om te bespreek | 8,96 | — |
Opbrengs op bates | 5,87% | — |
Opbrengs op kapitaal | 6,50% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 29,53 m | 220,46% |
Kontant van bedrywe | 56,47 m | 83,07% |
Kontant van beleggings | 35,72 m | 180,46% |
Kontant van finansiering | -100,55 m | -47 531,13% |
Netto kontantverandering | -7,86 m | 41,42% |
Beskikbare kontantvloei | 36,71 m | 54,92% |
Meer oor
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm. Wikipedia
Gestig
2004
Webwerf
Werknemers
4 200
